As acquisition multiples rise, more healthcare platforms build growth from de novos: new locations opened from scratch in markets where the platform already has a brand. A de novo costs less than an acquisition and comes with no legacy systems to clean up. The tradeoff is time. An acquired practice comes with patients. A de novo opens with an empty schedule, and every month it spends below breakeven is a drag on platform EBITDA.
Where De Novo Ramps Lose Time
Most de novos do not struggle because there is no demand. They struggle because the demand that does exist leaks out:
- Thin staffing at opening. A new location often opens with one or two front-desk staff, who cannot answer every call while checking in patients.
- Marketing spend with no follow-through. Paid search and mailers generate calls and form fills, but slow responses mean many never become appointments.
- No reviews yet. A new location starts with zero Google reviews, which hurts it in local search exactly when it needs visibility most.
- No recall base. Without existing patients, there is no recall list to fill gaps in the schedule.
- Each opening reinvents the process. Without a standard playbook, every de novo builds its own scripts and workflows.
Using AI From Day One
The platform's existing locations have already worked out what good looks like. AI lets a de novo start there instead of learning it again:
- Every inquiry answered. Operations Engine (AIT) answers calls, texts and web forms 24/7 and books directly into the schedule, so marketing dollars convert.
- Speed to lead. Web form leads get a response in seconds, not the next business day.
- Reviews from the first week. Automated review requests after each visit build the location's Google profile from the start.
- Overflow to sister locations. When the de novo is booked or a provider is out, patients can be offered nearby platform locations instead of being lost.
- The proven playbook on day one. Rollup Engine (AIP) applies the platform's scheduling rules, scripts and workflows to the new location before it opens.
Illustrative Ramp Math
Consider a de novo that needs 18 months to reach breakeven at its current pace, losing an average of $25K a month on the way. If faster response, better conversion and early reviews pull breakeven forward by four months, the platform avoids roughly $100K in operating losses on that one location and starts earning on it sooner. A platform opening six de novos a year multiplies that.
Your numbers will differ by specialty and market. The point is that the ramp is mostly a conversion problem, and conversion is something the platform can control.
KPIs to Track for Every De Novo
- Inbound inquiries by source, and the share that become booked appointments
- Time to first response for web and text leads
- New-patient visits per week against the ramp plan
- Schedule fill rate by provider
- Google review count and average rating
- Cost per acquired patient by marketing channel
Tracking the same KPIs at every location makes it possible to compare a de novo's ramp with the last one, and to spot problems in month two instead of month ten.
Next Step
See how Samara works for private equity platforms, or book a demo to plan your next opening.
Frequently Asked Questions
What slows down a de novo healthcare location's ramp?
Thin staffing, slow responses to marketing leads, no online reviews, no recall base and no standard playbook. Most of the lost time comes from demand that is generated but never converted to appointments.
How does AI help a de novo reach breakeven faster?
AI answers every inquiry around the clock, responds to web leads in seconds, requests reviews after each visit, and applies the platform's proven workflows from opening day.
Can Samara be live before a new location opens?
Yes. Samara can be configured with the platform's playbook before opening, so the location takes bookings from its first inquiry.